An interventional study of Lupeol and Control vehicle in Acne, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2014-06-02.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment
For the chemical lupeol isolated from eggplant, we applied it to one side of face, and applied vehicle control to another side for 8 -weeks. The study was performed in a 8-week, randomized controlled, split face fashion. Investigators evaluated safety and efficacy during baseline, 2 weeks, 4weeks, and 8 weeks after beginning of study.
Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients are supposed to apply lupeol on one side of face two times per day for 8 weeks
Drug: Lupeol
Patients are supposed to apply vehicle control to another side of face two times per day for 8 weeks
Drug: Control vehicle
Patients are supposed to apply lupeol cream to one side of their face two times per day for 8 weeks.
Also known as: no brand name
Patients are supposed to apply their control vehicle to the other side of their face for 8 weeks
Also known as: No brand name
Acne lesion counts as a measure of efficacy
Both inflammatory \& non-inflammatory acne lesions of both of their facial sides
Time frame: 8 weeks after beginning of applications
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
Among total patients enrolled in this study, number of patients either experiencing objective adverse events or subjective uncomfortableness were counted
Time frame: 8 weeks after beggning of applications
This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital